Autism Disorders Conference Evaluation - November 3, 2021

Please score your agreement with or assessment of the following questions and statements by rating on a scale of 1 to 5, with 5 representing the highest level of satisfaction or agreement. *

Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable

	5	4	3	2	1	NA
The skills learned in this CME course enhanced my professional competence.	The skills learned in this CME course enhanced my professional competence. - 5	The skills learned in this CME course enhanced my professional competence. - 4	The skills learned in this CME course enhanced my professional competence. - 3	The skills learned in this CME course enhanced my professional competence. - 2	The skills learned in this CME course enhanced my professional competence. - 1	The skills learned in this CME course enhanced my professional competence. - NA
The skills learned in this CME course will be applied in the treatment of my patients	The skills learned in this CME course will be applied in the treatment of my patients - 5	The skills learned in this CME course will be applied in the treatment of my patients - 4	The skills learned in this CME course will be applied in the treatment of my patients - 3	The skills learned in this CME course will be applied in the treatment of my patients - 2	The skills learned in this CME course will be applied in the treatment of my patients - 1	The skills learned in this CME course will be applied in the treatment of my patients - NA

How confident are you in your ability to: *

5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence

	5	4	3	2	1
How confident are you in your ability to select patients with autism that would benefit from available research programs?	How confident are you in your ability to select patients with autism that would benefit from available research programs? - 5	How confident are you in your ability to select patients with autism that would benefit from available research programs? - 4	How confident are you in your ability to select patients with autism that would benefit from available research programs? - 3	How confident are you in your ability to select patients with autism that would benefit from available research programs? - 2	How confident are you in your ability to select patients with autism that would benefit from available research programs? - 1

How satisfied or dissatisfied were you with the Speaker's effectiveness in addressing the learning objectives? *

Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied

	5	4	3	2	1
Discuss the scope, impact and promise of the world’s largest autism study, SPARK, and how they can contribute to this one-of-a-kind initiative to better understand the genetics of autism.	Discuss the scope, impact and promise of the world’s largest autism study, SPARK, and how they can contribute to this one-of-a-kind initiative to better understand the genetics of autism. - 5	Discuss the scope, impact and promise of the world’s largest autism study, SPARK, and how they can contribute to this one-of-a-kind initiative to better understand the genetics of autism. - 4	Discuss the scope, impact and promise of the world’s largest autism study, SPARK, and how they can contribute to this one-of-a-kind initiative to better understand the genetics of autism. - 3	Discuss the scope, impact and promise of the world’s largest autism study, SPARK, and how they can contribute to this one-of-a-kind initiative to better understand the genetics of autism. - 2	Discuss the scope, impact and promise of the world’s largest autism study, SPARK, and how they can contribute to this one-of-a-kind initiative to better understand the genetics of autism. - 1
Explain the processes and evaluate the challenges in identifying and returning autism-related results to study participants.	Explain the processes and evaluate the challenges in identifying and returning autism-related results to study participants. - 5	Explain the processes and evaluate the challenges in identifying and returning autism-related results to study participants. - 4	Explain the processes and evaluate the challenges in identifying and returning autism-related results to study participants. - 3	Explain the processes and evaluate the challenges in identifying and returning autism-related results to study participants. - 2	Explain the processes and evaluate the challenges in identifying and returning autism-related results to study participants. - 1
Review SPARK-related genetic findings including a list of autism risk genes and copy number variants identified by SPARK which can be useful for physicians to understand in clinical practice.	Review SPARK-related genetic findings including a list of autism risk genes and copy number variants identified by SPARK which can be useful for physicians to understand in clinical practice. - 5	Review SPARK-related genetic findings including a list of autism risk genes and copy number variants identified by SPARK which can be useful for physicians to understand in clinical practice. - 4	Review SPARK-related genetic findings including a list of autism risk genes and copy number variants identified by SPARK which can be useful for physicians to understand in clinical practice. - 3	Review SPARK-related genetic findings including a list of autism risk genes and copy number variants identified by SPARK which can be useful for physicians to understand in clinical practice. - 2	Review SPARK-related genetic findings including a list of autism risk genes and copy number variants identified by SPARK which can be useful for physicians to understand in clinical practice. - 1
Assess promising therapeutic pathways that may be opened with genetic results from SPARK in time.	Assess promising therapeutic pathways that may be opened with genetic results from SPARK in time. - 5	Assess promising therapeutic pathways that may be opened with genetic results from SPARK in time. - 4	Assess promising therapeutic pathways that may be opened with genetic results from SPARK in time. - 3	Assess promising therapeutic pathways that may be opened with genetic results from SPARK in time. - 2	Assess promising therapeutic pathways that may be opened with genetic results from SPARK in time. - 1

Was this course fair, balanced and without commercial bias? *

Yes

If you checked "No,” please explain why: *

What, if any, new skills/strategies will you apply in your clinical practice? *

If you do not plan to implement any new skills/strategies in your clinical practice, what is keeping you from doing so? *

Please provide any additional comments or suggestions.

Name

Leave this field blank

You are here

Autism Disorders Conference Evaluation - November 3, 2021